Evidence Hub

Recurrent Urinary Tract Infection Caused by Multidrug-Resistant Klebsiella pneumoniae: A Case Report

Monteiro ASS, Galvão VS, Silva CMP, Cordeiro SM, Reis JN

Case reports in infectious diseases, 2026

Abstract

Klebsiella pneumoniae is the second most common cause of urinary tract infection (UTI) in most populations; however, few cases of recurrent UTI (rUTI) have been described. In this report, we described a patient who experienced 18 episodes of community-acquired rUTI caused by extended-spectrum β-lactamase (ESBL)-producing and multidrug-resistant (MDR) K. pneumoniae over an 8-year period. All isolates were ESBL producers and MDR, with variable resistance profiles. Molecular analysis of 10 isolates also revealed variations in β-lactamase genes; however, all isolates shared the same capsular serotype (K17) and virulence gene profile. PFGE analysis identified three closely related pulsotypes, and all isolates belonged to ST101, supporting relapse events during recurrent infection. Particular attention should be paid to empirical treatment of UTI due to the high resistance rates observed in K. pneumoniae, even in community-acquired infections.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free